Cisco Systems Inc: 2 directors

A director at Cisco Systems Inc sold/sold after exercising options 27,000 shares at 77.208USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...

Bible 3Q25 – Enterprise IT: Legacy and SaaS growth stable, Cloud servi...

Today, we are publishing the Enterprise IT section of our 29th Tech Infrastructure Quarterly Bible. The Tech Bible is a must-read for any tech investor, as it summarizes the quarterly earnings reports from the over 140 companies we track, providing an update on our key perspectives and convictions. Legacy IT spending is stabilizing after a strong 2H24, while public-cloud growth accelerates on broad-based strength across AI and traditional workloads. SaaS revenue growth remains in the low-teens ...

Cisco: AI and campus refresh set to accelerate growth

Cisco’s growth is set to accelerate from low single-digits historically to high-single-digits in the coming years, driven by DCI optics, AI switching, and a likely campus refresh cycle. Please click the link below for more details.

Latam Chart Book - 18 December 2025 - Lucror Analytics

The LatAm Chart Book features relative-value charts and bond tables by country.

PSA Media & Entertainment: PS5 Outsells Switch 2 in Nov / Sony’s (6758...

This note contains two articles related to Sony: One highlighting how November sales of the 5-yr-old PS5 is outselling the Switch 2 and an update on Sony’s new game Marathon. It is due in next year but PSA’s gaming expert, Pelham Smithers, is not expecting much.

Fibre 31: Second Party Opinion – Social Loan Assigned SQS2 Sustainabil...

We have assigned an SQS2 to Fibre 31's social loan, which is aligned with relevant principles and demonstrates a significant contribution to sustainability.

Bible 3Q25 – PCs: 2026 guided flat, weak refresh ahead

Today, we are publishing the PCs section of our 29th Tech Infrastructure Quarterly Bible. The Tech Bible is a must-read for any tech investor, as it summarizes the quarterly earnings reports from the over 140 companies we track, providing an update on our key perspectives and convictions. PC revenue growth sustained, driven by RoW, while N.A. softened following 1H25 tariff-related pull-ins. Despite the ongoing Windows 10 and AI PC refresh cycle, OEMs guided 2026 PC units flat-to-down, with limi...

Bible 3Q25 – Hyperscale & Cloud: 2026 capex expectations up another 1...

Today, we are publishing the Hyperscale & Cloud section of our 29th Tech Infrastructure Quarterly Bible. The Tech Bible is a must-read for any tech investor, as it summarizes the quarterly earnings reports from the over 140 companies we track, providing an update on our key perspectives and convictions. We will publish sections on Telecom Equipment, Industrials, PCs, Enterprise IT, and Foundry later this week. Hyperscale revenues grew 16% YoY, with cloud services up nearly 30%. Capacity constra...

More Punch Left in the Punchbowl: Market Outlook Remains Positive

China Healthcare Bi-Weekly: Short-term Profit-taking Masks Solid Funda...

China healthcare stocks were relatively weak during the first two weeks of Dec 25 as investors took profits, particularly for internet healthcare and drug innovator names. Fundamentals remain solid, supported by the new commercial insurance policy, lower costs of capital, and robust pipelines. Despite rising competition in areas like generics, GLP-1 drugs and surgical robots, companies continue to advance towards sustainable growth. Maintain OVERWEIGHT. Our top picks are BeOne Medicines, Hansoh ...

Benelux Morning Notes

Belgian Telecoms: DIGI Belgium CEO Interview: ‘We are running a marathon, not a sprint' IBA: IBA to install a Rhodotron in East China. Ontex: Another quarter, another profit warning. Theon International: Backlog visibility indeed. Xior: 2026 outlook positive but with no major surprise. Events Calendar

Unilever/We're taking the MICC out of our forecasts/HOLD (previously B...

With the demerger of the Magnum Ice Cream Company (MICC) from Unilever, we have taken the MICC out of our forecasts for Unilever and lowered our consumer price inflation expectations for 2026 to a normalised level. The net result is that our EPS forecast for 2026F declines by 24% to €2.77, which is 11.2% below Bloomberg consensus estimates. Based on peer PER multiples for 2026F, we lower our 12-month target price from €58.90 to €52 and change our recommendation from Buy to HOLD as we believe tha...

PSA Media & Entertainment: Video Game Round-Up

This report by global gaming analyst Pelham Smithers recaps (1) the recent video game data,(2) which was the best game of 2025 and (3) what is happening to online discounts for Switch 2.

QUALCOMM Incorporated - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

China Internet: 3Q25 Results Recap: Strong AI Cloud Top-line Growth; L...

China’s internet companies reported resilient 3Q25 top-line growth and continuous margin improvement in the online gaming and OTA sectors, empowered by improved AI efficiency and benign competition. Margin pressure in e-commerce due to the intense on-demand delivery competition is likely to ease in 4Q25, but could persist into 2026 given the continuous investment and tough comparison base boosted by the trade-in programme in 2025. Maintain MARKET WEIGHT. Top BUYs: Alibaba, Tencent, TCOM, TME, Ne...

Bible 3Q25 – Ride-sharing & Delivery: Growth accelerating; margin expa...

Today, we are publishing the Ride-sharing and delivery section of our 29th Tech Infrastructure Quarterly Bible. The Tech Bible is a must-read for any tech investor, as it summarizes the quarterly earnings reports from the over 140 companies we track, providing an update on our key perspectives and convictions. In the coming weeks we will publish sections on Automotive, Memory, Hyperscale & Cloud, Telecom Equipment, Industrials, PCs, Enterprise IT, Foundry, and Semicap Equipment. Bookings across...

China Healthcare Bi-Weekly: Amid Market Decline, Drug Innovators Show ...

Most Chinese healthcare stock prices fell along with the weak Hang Seng Index in the past two weeks. The share prices of leading drug innovators, however, have remained relatively stable. We expect drug innovators to continue to outperform, supported by possible further lowering of interest rates, increasing innovative product launches, and globalisation efforts. Meanwhile, geopolitical risks and GPO and other policy uncertainties will remain as key risks amid the recovery for CROs, medical serv...

Regional Morning Meeting Notes: Monday, December 01, 2025

Greater China Economics | PMI November PMI undershot expectations; manufacturing PMI was at 49.2 (+0.2pt mom) and non-manufacturing PMI slipped to 49.5 (-0.6pt mom), the first contraction in nearly three years. With the services industry index weakened to 49.5 (-0.7pt mom). PMI data confirms growth momentum is easing, so expect more supportive policies to be rolled out soon, but for economic confidence to return, we need a sustainable bottom in the real estate sector. Sector Update | Heal...

Alibaba Health Information Technology (241 HK): 1HFY26: Results Beat; ...

Ali Health’s 1HFY26 revenue and adjusted net profit grew 17.0% and 38.7% yoy respectively, beating our and consensus FY26 estimates. It reaffirmed FY26 revenue and adjusted net profit growth targets of 10-15% and 20-30% yoy respectively. We expect robust FY26-28 CAGRs of 13% and 24% for its revenue and adjusted net profit, driven by sustained innovative drugs/healthcare products momentum, deepened synergies with Alibaba’s ecosystem, and expanding AI adoption. Maintain BUY and target price of HK$...

Greater China Daily: Friday, November 28, 2025

Top Stories Strategy | Market Strategy Global liquidity is expected to stay supportive through 1H26 following the Fed’s Sep 25 rate cut, lifting emerging-market assets and commodities. Chinese equities should extend gains, with MSCI China targeted at 104 on 16.3x forward PE and 6% EPS growth. Growth will rely more on domestic demand amid geopolitical risks and slowing external momentum. China’s GDP growth for 2026 is projected to rise 4.2% yoy. We favour AI/semiconductors, automation/robotics, ...